Midori Kojima - Concepedia

Author

Midori Kojima

The University of Osaka

Also Known As

Midori KOJIMA, Midori Kojima

Publications

793

Citations

H-Index

Concepts

All Affiliations

The University of Osaka National Institute of Advanced Industrial Science and Technology University of the Ryukyus Hirosaki University

About

Midori Kojima is an author at The University of Osaka specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	670
2	Cell Biology	4	4	659
3	Health Sciences	3	3	265
4	Cellular Therapies	2	2	510
5	Engineering	1	1	105

Midori Kojima

Publications

749

Citations

H-Index

Page 1

	Year	Citations
Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats Suguru Oyagi, Motohiro Hirose, Midori Kojima, Journal of Hepatology Regenerative MedicineCell TherapyTransplantationMarrow TransplantationTherapeutic Effect	2005	300
Multipotent cells from the human third molar: feasibility of cell-based therapy for liver disease Etsuko Ikeda, Kiyohito Yagi, Midori Kojima, Differentiation Regenerative MedicineCell TherapyHepatologyHuman Third MolarMultipotent Cells	2008	210
Proteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease Yuki Kitamura, Midori Kojima, Toshihito Kurosawa, Neuroscience Proteomic TechnologyEngineeringMedicineBiomarker TargetProteomics	2018	105
Maintenance of hepatocyte functions by coculture with bone marrow stromal cells Katsuhiro Isoda, Midori Kojima, Masashi Takeda, Journal of Bioscience and Bioengineering HepatologyLiver PhysiologyHistopathologyImmunologyHepatitis	2004	44
A sensitive column‐switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies Yumiko Akamine, Norio Yasui‐Furukori, Midori Kojima, Journal of Separation Science	2010	31
Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers Yumiko Akamine, Masatomo Miura, Norio Yasui‐Furukori, British Journal of Clinical Pharmacology	2011	25
Orally-Administered Caspase Inhibitor PF-03491390 Is Retained in the Liver for Prolonged Periods With Low Systemic Exposure, Exerting a Hepatoprotective Effect Against α-Fas-Induced Liver Injury in a Mouse Model Yoshinobu Ueno, Takashi Ohmi, Mitsuko L. Yamamoto, Journal of Pharmacological Sciences	2007	23
A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and cholesteryl ester transfer protein double transgenic mice Noriyuki Naya, Keita Fukao, Akemi Nakamura, Metabolism Metabolic SyndromeCardiovascular DiseaseSerum Lipoprotein ProfilesMedicinePhysiology	2015	11

Page 1